CompletedNot Applicable

Narrow Band Imaging (NBI) Against Lugol for Squamous Esophageal Cancer

180 participantsStarted 2006-04

Plain-language summary

This study aimed to compare Narrow Band Imaging (NBI) against Lugol chromoendoscopy for diagnosis of early esophageal cancers among high risk patients.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with Head and Neck Cancer
✓. Patients with esophageal cancer treated by chemoradiotherapy and in remission for 2 years
✓. Patients with esophageal cancer treated by endoscopic resection
✓. Age 18 to 80

Exclusion criteria

✕. Allergy to Lugol iodine
✕. Pregnancy
✕. Previous esophagectomy

What they're measuring

Diagnostic accuracy of superficial esophageal neoplasia

Timeframe: 1 month

Trial details

NCT IDNCT02002559

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-12

View on ClinicalTrials.gov More Superficial Esophageal Neoplasia trials